Microbot Medical (MBOT) Cash from Operations (2010 - 2026)

Microbot Medical has reported Cash from Operations for 17 years, with the latest figure at 5053000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 75.82% year-over-year to 5053000.0; the trailing twelve-month figure through Mar 2026 stood at 15225000.0 (down 64.04% YoY), and the FY2025 full-year result was 13046000.0, down 47.8% from the prior year.
• Cash from Operations for Q1 2026 stood at 5053000.0, down from 3758000.0 in the prior quarter.
• The five-year high for Cash from Operations was 1655000.0 in Q3 2023, with the low at 5053000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 2765176.47 across 5 years, with a median of 2759000.0 in 2024.
• Annual changes were most pronounced in 2023 — Cash from Operations jumped 43.99% — and 2025, when it slumped 122.24%.
• Microbot Medical's Cash from Operations stood at 2463000.0 in 2022, then increased by 26.07% to 1821000.0 in 2023, then increased by 7.14% to 1691000.0 in 2024, then slumped by 122.24% to 3758000.0 in 2025, then tumbled by 34.46% to 5053000.0 in 2026.
• The last three Cash from Operations figures came in at 5053000.0 (Q1 2026), 3758000.0 (Q4 2025), and 3841000.0 (Q3 2025), per Business Quant data.